Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

End of 2013, MSF initiated the restructuring and renovation of the central laboratory of Koutiala hospital, where MSF manages the pediatric unit. Photograph by Aurelie Baumel Photograph by Aurelie Baumel
Press release
Press release |
08 July 2017
Tuberculosis
G20

G20 Final Declaration: The G20 falls short of expectations in the healthcare sector

2 min
XDR-TB patient Hanif, in the waiting area outside MSF’s clinic in Mumbai. Photograph by Atul Loke Photograph by Atul Loke
Press release
Press release |
05 July 2017
Tuberculosis

New report reveals that countries are still not tackling tuberculosis, the world’s deadliest infectious disease

5 min
Activists from Doctors Without Borders protest vaccine pricing policies in front of the Pfizer World Headquarters in New York NY, Thursday, April 22, 2015. Pfizer refuses to publish the price of the pnuemococcal vaccine, preventing developing countries from negotiating a fair price for the drug. Photograph by Victor J. Blue
Press release
Press release |
27 June 2017
Intellectual property and trade

Proposed executive order puts pharma interests over people’s lives

Incredible India truck in front of Whitehouse Photograph by Ken Cedeno
Press release
Press release |
26 June 2017
Intellectual property and trade
India

MSF urges India’s Modi to remain committed to affordable medicines during White House meeting

4 min
Press release |
22 June 2017
Tropical & neglected diseases

MSF welcomes WHO’s decision to include snakebite on its Neglected Tropical Diseases list

Girl with post Kala Azar Dermal Leishmaniasis, a recurrent but non-fatal form of Kala Azar that affects 5-10 per cent of patients between six months to three years after cure. Photograph by Matthew Smeal
Press release
Press release |
07 June 2017
Research and development

US Congressional Committee advances legislation that fails to fix FDA PRV program for neglected diseases

Gloria Chipasula, 11 years old MSF's HIV and TB positive patient stands in in the middle of the road (green dressed) as she plays with her young relatives and village's friends. Photograph by Luca Sola
Press release
Press release |
06 June 2017
HIV/AIDS
India

Press note: Child-friendly formulation of WHO-recommended HIV treatment now approved by the CDSCO

5 min
FTA Protest Photograph by Siddharth Singh
Press release
Press release |
29 May 2017
Intellectual property and trade
SwitzerlandIndia

MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury